Vitiligo is a long-term skin disease in which patches of the skin lose their color. The skin patches affected by the disease Vitiligo become white. This happens because melanocytes within the skin die off. The skin pigmentation, melanin, due to which skin has its color, protection from solar UV rays this all happens because of melanocytes cells. Growing per capita healthcare expenditure, improving healthcare infrastructure in developing countries, growing diseases awareness and expected approval of Vitiligo drugs are some of the driving force for the growth of this market. However, the shortage of dermatologists and available treatments having a longer duration of times are major challenges for the growth of this market. According to this research, global Vitiligo market will be US$ 2.4 Billion by the year 2024.
Vitiligo disease prevalence varies between race, regions, and countries. It is expected that overall prevalence falls between 1-2 percent of the total population. Although Vitiligo disease can arise at any age, it mostly occurs to young and middle age people. At present globally over 21 Million people has suffered from this diseases. There is a number of drugs manufacture working for Vitiligo drugs development across various parts of the globe such as AXIM Biotechnologies, Boston Pharmaceutical, Castle Creek Pharma, Dermavant Sciences, JN Biosciences, Bristol-Myers Squibb, Incyte Corporation, Clinuvel Pharmaceuticals etc. and their Vitiligo drugs development are in various stages.
This report titled “Global Vitiligo Market, Patients By Countries (United States, United Kingdom, France, Germany, Italy, India, China, Japan), Drugs (ARN-4079, ATI-502, AX-1602, BOS-47, CCP-070, Cerdulatinib (RVT-502), HuABC-2, Abatacept, Topical Ruxolitinib, VLRX-001) Companies (AXIM Biotechnologies, Incyte Corporation, Bristol-Myers Squibb, Clinuvel Pharmaceuticals), Clinical Study, Growth Drivers, Challenges” provides a complete analysis of global vitiligo drugs market.
India and China are Key Contributors in the Global Vitiligo Patient Population
Vitiligo patient’s population is growing across all parts of the world. Patient’s growth rates vary in the countries covered in the report United States, United Kingdom, France, Germany, Italy, India, China, and Japan. India and China are key contributors to the global vitiligo patient population.
Vitiligo Pipe Line Drugs are Key Strength for this Market Place
In the global vitiligo market, vitiligo pipeline drugs will play a major role in the growth of this market. At present several drugs such as ARN-4079, ATI-502, AX-1602, BOS-47, CCP-070, Cerdulatinib (RVT-502), HuABC-2, Abatacept, Topical Ruxolitinib, VLRX-001 etc. are in preclinical, IND, Phase I, Phase II and Phase III stage.
Key Drugs Development Companies are working in this Market Place
Key drugs development companies are working in this marketplace across various parts of the globe such as AXIM Biotechnologies, Boston Pharmaceutical, Castle Creek Pharma, Dermavant Sciences, JN Biosciences, Bristol-Myers Squibb, Incyte Corporation, Clinuvel Pharmaceuticals etc.
Segments - Global Vitiligo Market
- Vitiligo Patients Population
- Vitiligo Market
Countries - Global Vitiligo Market
- United States
- United Kingdom
- France
- Germany
- Italy
- India
- China
- Japan
Global Vitiligo Market - Drugs Profile Covered
- ARN-4079
- ATI-502
- AX-1602
- BOS-47
- CCP-070
- Cerdulatinib (RVT-502)
- HuABC-2
- Abatacept
- Topical Ruxolitinib
- VLRX-001
Companies Covered
- AXIM Biotechnologies
- Incyte Corporation
- Bristol-Myers Squibb
- Clinuvel Pharmaceuticals
Each Company Covered in this Report has Following Details
- Company Overview
- Company Initiatives
- Financial Insight
Table of Contents
Companies Mentioned
- AXIM Biotechnologies
- Boston Pharmaceutical
- Bristol-Myers Squibb
- Castle Creek Pharma
- Clinuvel Pharmaceuticals
- Dermavant Sciences
- Incyte Corporation
- JN Biosciences
Methodology
In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.
Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.
Primary Research
The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develop the analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth, and forecast
The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:
- Chief executives and VPs of leading corporations specific to the industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
- Key opinion leaders (KOLs)
Secondary Research
The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, webcasts, and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
LOADING...
